Symbols / GOVX Stock $1.33 -5.67% GeoVax Labs, Inc.

Healthcare • Biotechnology • United States • NCM
GOVX (Stock) Chart
About

GeoVax Labs, Inc., a clinical-stage biotechnology company, develops human vaccines and immunotherapies against infectious diseases and solid tumor cancers using novel proprietary platforms in the United States. The company is developing various preventive vaccines against (COVID-19), human immunodeficiency virus (HIV); Zika virus; malaria; and hemorrhagic fever viruses, such as Ebola, Sudan, Marburg, and Lassa, as well as therapeutic vaccines for HIV, chronic Hepatitis B infections, and solid tumor cancers. It also developing GEO-CM04S1, a vaccine candidate that is in Phase 2 clinical trial for the treatment of preventive COVID-19; Gedeptin, a novel patented product/technology for the treatment of solid tumors, and Phase 1/2 clinical trial for the treatment of advanced head and neck squamous cell carcinoma; and GEO-CM02, a pan-coronavirus vaccine. In addition, the company offers GEO-MVA-MUC1, a vaccine candidate, which is in preclinical trial for the treatment of solid tumor cancers; GEO-ZM02, a vaccine candidate, which is in preclinical trial for the treatment of Zika; GEO-EMO1-Z, which is in preclinical trial for the treatment of Ebola Zaire; GEO-EMO1-S, which is in preclinical trial for the treatment of Ebola Sudan; GEO-MM01 treatment for marburg; and GEO-MVA for the treatment of Mpox and small pox. It has collaboration and partnership agreements with the National Institute of Allergy and Infectious Diseases of the National Institutes of Health; U.S. Department of Defense; and the Burnet Institute. GeoVax Labs, Inc. was incorporated in 1988 and is headquartered in Smyrna, Georgia.

Fundamentals
Scroll to Statements
Sector Healthcare Industry Biotechnology Market Cap 2.96M
Enterprise Value -3.43M Income -25.31M Sales 3.35M
Book/sh 4.13 Cash/sh 4.22 Dividend Yield —
Payout 0.00% Employees 17 IPO —
P/E — Forward P/E -1.55 PEG —
P/S 0.88 P/B 0.32 P/C —
EV/EBITDA 0.14 EV/Sales -1.02 Quick Ratio 2.75
Current Ratio 3.57 Debt/Eq — LT Debt/Eq —
EPS (ttm) -31.75 EPS next Y -0.86 EPS Growth —
Revenue Growth — Earnings 2026-03-23 ROA -178.93%
ROE -3.77% ROIC — Gross Margin 0.00%
Oper. Margin -7.62% Profit Margin 0.00% Shs Outstand 2.22M
Shs Float 1.19M Short Float 11.95% Short Ratio 1.95
Short Interest — 52W High 34.75 52W Low 1.26
Beta 3.81 Avg Volume 135.27K Volume 89.32K
Target Price $270.83 Recom Strong_buy Prev Close $1.41
Price $1.33 Change -5.67%
Valuation Models

Price estimates from analyst targets and simple models.

1. Analyst consensus
$270.83
Mean price target
2. Current target
$1.29
Latest analyst target
3. DCF / Fair value
$-121.12
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$1.29
Low
$212.50
High
$350.00
Mean
$270.83

Latest analyst rating changes

Date Action Analyst Rating Change Price Target
2026-02-19 down D. Boral Capital Buy → Hold —
2026-01-21 main D. Boral Capital Buy → Buy $6
2025-11-19 main D. Boral Capital Buy → Buy $6
2025-09-26 main D. Boral Capital Buy → Buy $9
2025-08-07 main D. Boral Capital Buy → Buy $9
2025-07-29 main D. Boral Capital Buy → Buy $9
2025-07-17 main D. Boral Capital Buy → Buy $9
2025-06-16 main D. Boral Capital Buy → Buy $9
2025-05-02 main D. Boral Capital Buy → Buy $9
2025-04-16 reit HC Wainwright & Co. Buy → Buy $8
2025-04-15 main D. Boral Capital Buy → Buy $14
2025-04-10 main D. Boral Capital Buy → Buy $18
2025-03-28 main D. Boral Capital Buy → Buy $18
2025-02-27 main D. Boral Capital Buy → Buy $18
2025-01-31 main D. Boral Capital Buy → Buy $18
2025-01-16 main D. Boral Capital Buy → Buy $18
2024-12-18 main D. Boral Capital Buy → Buy $18
2024-11-20 reit HC Wainwright & Co. Buy → Buy $8
2024-11-19 main D. Boral Capital Buy → Buy $18
2024-11-15 reit HC Wainwright & Co. Buy → Buy $8
Insider Transactions
Filed Date Insider Relationship Transaction Shares Price Value SEC
2025-10-17 SPENCER JOHN N JR Director — 10,000 $0.55 $5,498
2025-08-07 MCKEE KELLY T JR. Officer — 1,107 $0.67 $742
2025-04-10 SHARKEY JOHN W PH.D. Officer — 6,000 $0.99 $5,940
2025-04-01 DODD DAVID A Chief Executive Officer — 10,000 $1.08 $10,800
2025-03-31 REYNOLDS MARK W Chief Financial Officer — 6,800 $1.08 $7,343
2024-08-09 DODD DAVID A Chief Executive Officer — 8,000 $1.95 $15,600
2024-02-22 DODD DAVID A Chief Executive Officer — 8,729 $2.15 $19,781
2024-02-07 REYNOLDS MARK W Chief Financial Officer — 2,000 $2.77 $5,540
Financials
Statement View
Amounts in millions (2 decimals, no suffix) • EPS per share (2 decimals) • Trend = period evolution • YoY Growth = previous period %
Line Item Trend 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Total Revenue
3.95
0.00
-100.00%
0.08
-78.85%
0.39
Operating Revenue
3.95
0.00
-100.00%
0.08
-78.85%
0.39
Operating Expense
29.10
+8.81%
26.74
+89.53%
14.11
-26.25%
19.13
Research And Development
23.71
+14.44%
20.72
+127.11%
9.12
-41.34%
15.55
Selling General And Administration
5.39
-10.58%
6.02
+20.77%
4.99
+39.40%
3.58
General And Administrative Expense
5.39
-10.58%
6.02
+20.77%
4.99
+39.40%
3.58
Other Gand A
5.39
-10.58%
6.02
+20.77%
4.99
+39.40%
3.58
Total Expenses
29.10
+8.81%
26.74
+89.53%
14.11
-26.25%
19.13
Operating Income
-25.14
+5.98%
-26.74
-90.63%
-14.03
+25.16%
-18.75
Total Operating Income As Reported
-25.14
+5.98%
-26.74
-90.63%
-14.03
+25.16%
-18.75
EBITDA
-24.88
+3.93%
-25.89
-85.31%
-13.97
+24.60%
-18.53
Normalized EBITDA
-24.88
+3.93%
-25.89
-85.31%
-13.97
+25.29%
-18.70
Reconciled Depreciation
0.10
+28.58%
0.07
+31.78%
0.06
+46.11%
0.04
EBIT
-24.97
+3.84%
-25.97
-85.10%
-14.03
+24.45%
-18.57
Total Unusual Items
—
—
0.00
-100.00%
0.17
Total Unusual Items Excluding Goodwill
—
—
0.00
-100.00%
0.17
Special Income Charges
—
—
0.00
-100.00%
0.17
Other Special Charges
—
—
—
-0.17
Net Income
-24.99
+3.75%
-25.97
-85.20%
-14.02
+24.50%
-18.57
Pretax Income
-24.99
+3.75%
-25.97
-85.20%
-14.02
+24.50%
-18.57
Net Non Operating Interest Income Expense
0.15
-80.42%
0.78
+10333.89%
0.01
+115.62%
0.00
Interest Expense Non Operating
0.02
0.00
0.00
-100.00%
0.00
Net Interest Income
0.15
-80.42%
0.78
+10333.89%
0.01
+115.62%
0.00
Interest Expense
0.02
0.00
0.00
-100.00%
0.00
Interest Income Non Operating
0.17
-77.67%
0.78
+10333.89%
0.01
+57.07%
0.00
Interest Income
0.17
-77.67%
0.78
+10333.89%
0.01
+57.07%
0.00
Other Income Expense
—
—
—
0.17
Tax Rate For Calcs
0.00
0.00
0.00
0.00
Tax Effect Of Unusual Items
0.00
0.00
0.00
0.00
Net Income Including Noncontrolling Interests
-24.99
+3.75%
-25.97
-85.20%
-14.02
+24.50%
-18.57
Net Income From Continuing Operation Net Minority Interest
-24.99
+3.75%
-25.97
-85.20%
-14.02
+24.50%
-18.57
Net Income From Continuing And Discontinued Operation
-24.99
+3.75%
-25.97
-85.20%
-14.02
+24.50%
-18.57
Net Income Continuous Operations
-24.99
+3.75%
-25.97
-85.20%
-14.02
+24.50%
-18.57
Normalized Income
-24.99
+3.75%
-25.97
-85.20%
-14.02
+25.19%
-18.74
Net Income Common Stockholders
-24.99
+3.75%
-25.97
-85.20%
-14.02
+24.50%
-18.57
Diluted EPS
-120.50
+66.27%
-357.25
-14.78%
-311.25
+72.70%
-1,140.00
Basic EPS
-120.50
+66.27%
-357.25
-14.78%
-311.25
+72.70%
-1,140.00
Basic Average Shares
0.21
+185.43%
0.07
+60.60%
0.05
+178.26%
0.02
Diluted Average Shares
0.21
+185.43%
0.07
+60.60%
0.05
+178.26%
0.02
Diluted NI Availto Com Stockholders
-24.99
+3.75%
-25.97
-85.20%
-14.02
+24.50%
-18.57
Line Item Trend 2023-12-31
Total Assets
9.28
Current Assets
7.89
Cash Cash Equivalents And Short Term Investments
6.45
Cash And Cash Equivalents
6.45
Receivables
0.00
Other Receivables
—
Prepaid Assets
1.43
Total Non Current Assets
1.40
Net PPE
0.21
Gross PPE
0.89
Accumulated Depreciation
-0.68
Properties
0.00
Machinery Furniture Equipment
0.77
Leases
0.12
Goodwill And Other Intangible Assets
0.07
Other Intangible Assets
0.07
Non Current Prepaid Assets
1.12
Other Non Current Assets
1.19
Total Liabilities Net Minority Interest
3.52
Current Liabilities
3.52
Payables And Accrued Expenses
3.52
Payables
2.80
Accounts Payable
2.80
Current Accrued Expenses
0.72
Total Non Current Liabilities Net Minority Interest
0.00
Other Non Current Liabilities
—
Stockholders Equity
5.76
Common Stock Equity
5.76
Capital Stock
0.00
Common Stock
0.00
Preferred Stock
—
Share Issued
0.08
Ordinary Shares Number
0.08
Treasury Shares Number
0.00
Additional Paid In Capital
110.13
Retained Earnings
-104.36
Total Equity Gross Minority Interest
5.76
Total Capitalization
5.76
Working Capital
4.37
Invested Capital
5.76
Net Tangible Assets
5.69
Tangible Book Value
5.69
Non Current Accrued Expenses
—
Line Item Trend 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Operating Cash Flow
-24.68
+1.98%
-25.17
-32.28%
-19.03
-69.97%
-11.20
Cash Flow From Continuing Operating Activities
-24.68
+1.98%
-25.17
-32.28%
-19.03
-69.97%
-11.20
Net Income From Continuing Operations
-24.99
+3.75%
-25.97
-85.20%
-14.02
+24.50%
-18.57
Depreciation Amortization Depletion
0.10
+28.58%
0.07
+31.78%
0.06
+46.11%
0.04
Depreciation
—
0.07
+31.78%
0.06
—
Depreciation And Amortization
0.10
+28.58%
0.07
+31.78%
0.06
+46.11%
0.04
Stock Based Compensation
0.53
-50.82%
1.07
+19.17%
0.90
+143.81%
0.37
Operating Gains Losses
—
—
—
0.04
Gain Loss On Investment Securities
—
—
—
0.21
Change In Working Capital
-0.31
+13.70%
-0.36
+94.03%
-5.97
-186.14%
6.93
Change In Receivables
-0.66
0.00
-100.00%
0.05
-63.33%
0.13
Change In Prepaid Assets
-0.35
-207.50%
-0.11
+90.18%
-1.17
-7064.75%
-0.02
Change In Payables And Accrued Expense
-0.41
+66.41%
-1.23
+54.31%
-2.69
-139.46%
6.81
Change In Other Working Capital
—
—
-2.16
—
Change In Other Current Assets
1.12
+13.21%
0.99
+145.60%
-2.16
—
Investing Cash Flow
-0.02
+57.80%
-0.05
+63.54%
-0.13
-181.36%
-0.05
Cash Flow From Continuing Investing Activities
-0.02
+57.80%
-0.05
+63.54%
-0.13
-181.36%
-0.05
Net PPE Purchase And Sale
-0.02
+57.80%
-0.05
+63.54%
-0.13
-181.36%
-0.05
Purchase Of PPE
-0.02
+57.80%
-0.05
+63.54%
-0.13
-181.36%
-0.05
Capital Expenditure
-0.02
+57.80%
-0.05
+63.54%
-0.13
-181.36%
-0.05
Financing Cash Flow
23.75
+484.64%
4.06
-88.51%
35.35
+176.54%
12.78
Cash Flow From Continuing Financing Activities
23.75
+484.64%
4.06
-88.51%
35.35
+176.54%
12.78
Net Issuance Payments Of Debt
-0.01
0.00
0.00
+100.00%
-0.03
Issuance Of Debt
0.14
0.00
—
0.00
Repayment Of Debt
-0.15
0.00
0.00
+100.00%
-0.03
Long Term Debt Issuance
—
—
—
0.00
Long Term Debt Payments
—
—
0.00
+100.00%
-0.03
Net Long Term Debt Issuance
—
—
0.00
0.00
Short Term Debt Issuance
0.14
0.00
—
0.00
Short Term Debt Payments
-0.15
0.00
0.00
+100.00%
-0.03
Net Short Term Debt Issuance
-0.01
0.00
0.00
+100.00%
-0.03
Net Common Stock Issuance
21.40
0.00
-100.00%
27.73
+194.69%
9.41
Repurchase Of Capital Stock
—
—
0.00
+100.00%
-0.00
Proceeds From Stock Option Exercised
2.37
-41.73%
4.06
-46.73%
7.63
+124.02%
3.40
Changes In Cash
-0.95
+95.53%
-21.16
-230.71%
16.19
+951.17%
1.54
Beginning Cash Position
6.45
-76.63%
27.61
+141.71%
11.42
+15.58%
9.88
End Cash Position
5.51
-14.66%
6.45
-76.63%
27.61
+141.71%
11.42
Free Cash Flow
-24.70
+2.09%
-25.22
-31.61%
-19.16
-70.44%
-11.24
Common Stock Issuance
21.40
0.00
-100.00%
27.73
+194.69%
9.41
Issuance Of Capital Stock
21.40
0.00
-100.00%
27.73
+194.69%
9.41
Net Preferred Stock Issuance
—
—
0.00
+100.00%
-0.00
Preferred Stock Issuance
—
—
—
0.00
Preferred Stock Payments
—
—
0.00
+100.00%
-0.00
SEC Filings

Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.

Trades
Date User Broker Pattern Type Position Size Entry Price Trade P&L Status
Posts
Published Title Author Category